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1. Introduction
1.1. Caveolae structure and morphogenesis
Morphologically described as small “caves” in the plasma membrane, caveolae are highly
specialized membrane domains with important roles in cell endocytosis, lipid metabolism,
and signaling. Since their discovery sixty years ago [1,2], the functional relevance of caveo‐
lae has challenged many scientists, raising numerous debates and controversies. The elec‐
tron microscopy images of caveolae show a rather cell-type-dependent appearance. In
endothelial cells, caveolae opening is more constricted [3], while in epithelial cells they ap‐
pear open to the extracellular medium and smaller in size [4]. In muscle cells, multiple cav‐
eolae units cluster together forming T-like tubules invaginating from sarcolemma [5].
Regardless their shape, caveolae appear as immobile structures, in tight connection with the
cortical actin cytoskeleton underlying the plasma membrane. Video microscopy and fluores‐
cence recovery after photobleaching analysis have shown that caveolae detach from the
membrane only upon ligand binding and specific signaling [6].
The discovery of caveolins (Cav), the structural proteins enveloping caveolae in a spike-like
coat [7] marked a significant breakthrough in understanding the nature and importance of
these organelles.
Three members of the Cav family have been described in mammalian cells, to date: Cav-1,
-2, -3, which share a significant homology and are conserved throughout evolution [8].
Cav-1 and -2 are relatively ubiquitous, with highest distribution in fibroblasts, adipocytes,
endothelial cells, and pneumocytes, being co-expressed in most cells types [9]. Cav-3 is ex‐
pressed independently of Cav-1 and -2 and is limited to skeletal muscle fibers and cardiac
myocytes [10-12]. Over-expression of Cav-1 in caveolae-deficient cells is necessary and ap‐
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parently sufficient to drive caveolae biogenesis [13]. Moreover, Cav-1 expression is required
for the membrane localization and stability of Cav-2. Although unable to drive caveolae bio‐
genesis on its own, Cav-2 may however influence it, at least in several polarized, epithelial
cells [14,15]. The capacity to modulate caveolae assembly, shape and size has been shown to
depend on Cav-2 phosphorylation status [16]. Similar to Cav-1, Cav-3 protein is sufficient to
drive formation of caveolae in muscle cells [17].
Most of the molecular data available on caveolins refer to Cav-1; therefore the following dis‐
cussion will focus on this protein, as a representative of the caveolin family, which is shown
schematically in Fig.1.
Cav-1 is an integral membrane protein of 21kDa with an unusual topology. Both the N- and
C-termini are cytoplasmically oriented and connected by a central hydrophobic domain,
comprising approximately residues 102-134, inserted into, but not spanning the membrane
bilayer, in a hairpin (or U bent, or horseshoe) configuration [18,19]. Interestingly, a peptide
corresponding to the last 20 residues of the hydrophilic N-domain, (amino acids 82–101) en‐
riched in aromatic residues, can also bind to membranes independently [20,21]. This so-
called caveolin scaffolding domain (CSD) is a highly conserved region responsible for many
functions associated with Cav-1.
In silico analysis of the conformation of this hydrophobic domain, showed that mutation of
a single residue, Pro (110), changes the stable conformation to a straight hydrophobic helix
that would span the membrane. Expression of the Cav-1 P110A mutant in HEK 293 cells fol‐
lowed by confocal immunofluorescence microscopy further confirmed the in silico data and
the estimated topology [22].
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Figure 1. Schematic presentation of the structural similarities of the caveolin family of proteins.
Very recently, circular dichroism and NMR spectroscopy analysis have shown that the
transmembrane domain of Cav-1 is primarily α-helical (57-65%). In addition, the helix–
break–helix structure was suggested to be critical for the formation of the intra-membrane
horseshoe conformation predicted for the protein. Interestingly, mutations of Ile (109) and
Pro (110) to Ala dramatically altered the helix-break-helix structure. Moreover, it was shown
that substitution of Pro (110) with any other residue results in disruption of the helix-break-
helix structure, confirming the importance of the residue in the stability of the hydrophobic
domain [23].
An important structural feature of Cav-1 is represented by its arrangement in high molecu‐
lar mass oligomers of about 350 kDa, composed of 14-16 individual molecules [24,25]. Oligo‐
merization is initiated in the endoplasmic reticulum (ER), where the Cav-1 monomer is co-
translationally inserted into the membrane [19] and is rapidly assembled to form SDS-
resistant, 8S complexes considered the building units of caveolae structure [24,25].
Intriguingly, blue native gel analysis evidenced only a few intermediate sized oligomers,
suggesting that Cav-1 oligomerization is a highly cooperative process [26]. Oligomerization
of the full-length protein requires the presence of the CSD and of the C-terminal domain [27]
and appears to be stabilized by the palmitoylation of cysteine residues located at positions
133, 143 and 156 [18,28]. At this stage of their assembly, the complexes appear highly mobile
in the ER membrane and rapidly concentrate at the ER exit sites, a process favored by the
existence of a di-acidic export sequence located at the N-terminal domain. In the absence of
this signal sequence, Cav-1 accumulates in lipid droplets [29,30]. This is an important obser‐
vation, suggesting that ER exit and lipid droplets localization of caveolin complexes are
competing processes, highlighting the role of the di-acidic motif in caveolin trafficking.
Interestingly, co-expression of Cav-1 and -2 results in assembly of mixt 8S complexes, where
the Cav-1 to Cav-2 ratio may vary from 2:1 to 4:1 [31]; however, expression of Cav-2 alone
does not result in oligomer formation.
The process continues in the trans-Golgi where the oligomers are exported in a COPII-de‐
pendent manner and self-associate into a large network of caveolin. However, formation of
the 8S complex is not a prerequisite for Golgi transport, as expression of Cav- 2 alone, as
well as that of an oligomerization-incompetent variant of Cav-1 does not result in their re‐
tention within the ER [32,33].
The Golgi oligomerization step is sensitive to BFA, clearly indicating that formation of large
oligomer complexes is dependent on caveolins trafficking to this compartment, probably re‐
quiring a specific lipid composition of the membrane. The assembly process continues in a
cholesterol-dependent manner, resulting in formation of 70S stable complexes, also evi‐
denced by using a panel of anti-Cav-1 conformational antibodies. These complexes were as‐
sumed to correspond to the intact protein scaffold of the caveolae structure [34]. It is
interesting that the caveolin assemblies colocalized with medial, rather than trans-Golgi
markers, suggesting that, unlike other cargos transported through the secretory pathway,
caveolar carrier vesicles are formed in the medial cisternae, being further exported to the
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plasma membrane in a dynamin-2 independent manner, similar to other raft-associated pro‐
teins [34]. This assembly process is schematically shown in Fig.2.
Figure 2. Caveolin oligomerization and assembly
It can be concluded from these observations that the tight regulation of Cav-1 trafficking
along the secretory compartments (and the multiple check points) is totally justified by the
complexity of the assembly process.
In addition to oligomerization, caveola formation involves association of the complexes with
cholesterol-rich lipid-raft domains at plasma membrane. It is estimated that Cav-1 binds to
1–2 cholesterol molecules through the conserved basic and hydrophobic residues of the scaf‐
folding domain [35]; thus, the relative amount of cholesterol concentrated in isolated caveo‐
lae can be as high as 20.000 molecules [36]. The relationship between cholesterol and
caveolins is very complex. Treatment of cells with cholesterol binding or depleting agents
results in caveolae with altered morphology and disrupted protein coat [7]. Moreover, cho‐
lesterol regulates Cav-1 expression at both, transcriptional and translational levels, through
binding to either two steroid regulatory elements in the Cav-1 promoter, or the protein it‐
self, thus modulating the level of Cav-1 mRNA or the protein stability [37,38].
Caveolae are enriched in glycosphingolipids (like GM1 and GM3) and sphingomyelin, the
total lipid density being significantly higher than within the rest of the plasma membrane
[36]. This is an important observation implying that certain lipids are recruited in caveolae,
possibly to ensure their invagination-competent composition.
Recently, a crucial role in the last steps of caveolae biogenesis has been attributed to PTRF
(Polymerase I and transcript release factor), originally described as an RNA Pol I transcrip‐
tion factor (also called Cav-P60 or cavin-1) [39,40]. Interestingly, cavin-1 is able to associate
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with plasma membrane caveolae but not with caveolins with other intracellular distribution
(such as Golgi caveolins) [34]. Cavin-1 is recruited by Cav-1 to plasma membrane caveolar
domains, where the two proteins are found to be in close proximity and an approximate ra‐
tion of 1:1 [39]; however, whether or not they directly interact with each other is still a mat‐
ter of debate. It was clearly demonstrated that cavins bind to phosphatidylserine and are
phosphorylated at multiple sites, suggesting they may act as regulatory proteins of caveolae
functions [41].
Based on sequence homology with cavin-1, three other proteins named cavin-2 to 4, sharing
similar molecular organization, have been identified as part of the cavin family [42-44].
While cavin-1 expression is strictly associated to that of Cav-1 [39] contributing to the stabili‐
ty of the caveolae unit like a scaffolding protein, cavin-2 promotes recruitment of cavin-1 in
caveolae and appears to have a role in the membrane-curvature [45].
The role of cavin-3 and -4 in caveolae biogenesis is less well understood. Cavin-3 was shown
to regulate caveolae budding and Cav-1 trafficking, suggesting a function in coupling caveo‐
lae to the intracellular transport network [44]. Cavin-4 is co-expressed with Cav-3 in cardiac
and muscle tissues where their function appears to be tightly correlated [42].
All members of the cavin family interact in a multimeric complex of about 60-80 cavins, in a
Cav-1 independent manner. These complexes were detected both in the cytosol and plasma
membrane fractions, suggesting they are the result of a succession of events, starting with
cavin association into the cytosol and ending with the recruitment of the multimeric com‐
plexes to caveolae, during the final step of their biogenesis [42].
In contrast to caveolins, cavins are peripheral membrane proteins, and bind molecular com‐
ponents of the caveolar domain facing the cytosol. Given the high affinity of cavins for phos‐
phatidylserine and the rapid dissociation from caveolae in the presence of nonionic
detergents, it was suggested that binding to the lipid membrane, rather than to the protein
scaffold, was highly probable.
The identification of cavins in caveolae opened new perspectives in understanding the com‐
plexity of caveolar structure. Although our knowledge on caveolae architecture and molecu‐
lar composition has improved since their discovery, the main structural pillars defined at
the time have not dramatically changed. Thus, today, caveolae are referred to as invagina‐
tions of the plasma membrane lipid bilayer, enriched in cholesterol and sphingolipids, em‐
bedding an integral membrane scaffold formed by caveolin oligomers assembled in a stable
network, peripherally covered by a protein layer of cavin complexes. Once formed, this
structure appears to remain stable also during endocytosis [46].
2. Caveolae signaling
The protein composition of caveolae has been addressed in a more systematic manner with‐
in the last years, using proteomic approaches [47-49]. A variety of signal transduction pro‐
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teins were found to localize in caveolae, in tight connection with either the CSD or the lipid
domains.
According to the caveolin signaling hypothesis, the role of caveolae is to trigger specific sig‐
nal transduction by concentrating downstream effectors close to plasma membrane recep‐
tors, through direct interaction with the CSD [50,51]. Palmitoylation appears to play an
important function in this process by facilitating the caveolar localization of proteins [52]. Of
the signaling molecules identified, several have been more thoroughly investigated:
a. G proteins were abundant in caveolae; their binding to caveolin has a role in maintain‐
ing the Gα subunits in an inactive GDP-bound state [53]. Small GTP-binding proteins of
the Ras superfamily also localized in caveolae, a process enhanced by palmitoylation of
the C-terminal hypervariable region [54,55]. Binding of the H-Ras to the CSD results in
inactivation of the protein, which is relevant in certain human cancers were H-Ras -cav‐
eolin interaction is prevented and the protein is maintained in an active state [56].
b. Src family kinases, such as c-Src, Fyn, Lyn [57] are nonreceptor tyrosine kinases, also
enriched in caveolae. Their localization depends on the N-terminal myristoylation and
subsequent interaction with the caveolins. Interestingly, Cav-1 palmitoylation is equally
important for caveolae/c-Src interaction [52], which results in c-Src and Fyn inactivation
[58]. In turn, the tyrosine phosphorylation of Cav-1 and -2 facilitates the recruitment of
matrix metalloproteinases [58,59], and promotes caveolins localization to focal adhe‐
sions [60,61].
c. Several steroid hormone receptors were localized in caveolae, a process depending on
both, palmitoylation and association with Cav-1 [62] and facilitating their activation
[63].
d. Endothelial nitric oxide synthase (eNOS) is one of the most extensively studied Cav-1
interacting protein [64]. eNOS binds to the CSD of both Cav-1 and -3, which inhibit its
enzymatic activity [65,66]. This observation lead to a novel concept of eNOS regulation,
whereby, the interaction with caveolins is necessary to keep the enzyme inactive under
basal conditions, while its concentration in caveolae will allow a quick response upon
stimulation [67].
e. Many ion channels and pumps are targeted to caveolae and interact with caveolins,
such as the calcium signaling molecules calmodulin, Ca2+-ATPase, L-type Ca2+ channels
[68,69]. Transient receptor potential (TRP) channels, and large-conductance Ca2+-activat‐
ed K+ channels also localize in cholesterol-rich membrane areas, suggesting an impor‐
tant role of these domains in Ca2+ homeostasis [70,71]. Other transporters, like the Na/K-
ATPase, involved in maintaining the Na+ membrane gradient, are also found in
caveolae, owing this localization to the existence of two caveolin-binding motifs in their
amino acid sequence [72].
f. Protein kinases of different families were found in caveolae, due to their direct interac‐
tion with the Cav-1 CSD. For PKA, this interaction results in inhibition of the enzymatic
activity [73], with consequences on regulation of other proteins, such as ATP-dependent
Endocytosis6
K+ channels or eNOS in muscle and endothelial cells, respectively [74,75]. Different iso‐
forms of the PKC family of enzymes are also caveolae resident and appear to participate
in regulation of caveolar proteins [76]. Caveolae interaction with PKC is more complex,
leading to either activation (via ceramide interaction) [77], or inactivation, following en‐
dosomal delivery [78]. Caveolae also recruit the phosphatidylinositol-3-kinase (PI3K)
through direct binding to Cav-1 [79] and the protein kinase B (PKB). Integration of this
signaling pathway by caveolae plays a significant role in managing the cellular physio‐
logical stress, and regulating cell survival and death [80].
g. Phosphodiesterases (PDEs), involved in cyclic nucleotides (cAMP and cGMP) hydroly‐
sis, have a preference for lipid rafts association (Abrahamsen H, 2004). For some iso‐
formes, such as PDE3B, a direct interaction with Cav-1, with a stabilizing effect on
PDE3B, has been clearly confirmed by co-immunoprecipitation [81]. Other PDEs (PDE5,
PDE4A4) appear to be recruited by caveoale through indirect mechanisms, possibly in‐
volving adapter proteins; [82]. Nevertheless, this association influences the establish‐
ment of cAMP/cGMP gradients and the downstream events [83].
3. Caveolae internalization and trafficking
Electron microscopy data show that caveolae are tightly connected to submembranous actin
filaments [84,85], suggesting a function of the cytoskeleton in caveolae-mediated endocyto‐
sis. However, the exact role of the actin cytoskeleton is not clearly defined, as its disruption
inhibits uptake of the caveolae ligand, alkaline phosphatase, on one hand [86] and promotes
clustering of caveolae and internalization of Cav-1-labeled vesicles, on the other hand [6,87].
These observations fit into a model whereby actin would play a dual role in caveolae inter‐
nalization: one is to keep the organization of caveolae and maintain their immobility at the
plasma membrane, and the other to promote vesicle budding and release from the mem‐
brane.
Caveolae endocytosis relies heavily on dynamin, a multi-domain GTPase [88,89], which was
shown to interact directly with Cav-1 [90]. Ligand binding initially disrupts the local actin
cytoskeleton and promotes dynamin II recruitment to the site of internalization [91,92]. Dy‐
namin oligomerization and the GTP-dependent conformational changes result in a structur‐
al collar around the neck of caveolae, directly mediating formation of free transport vesicles,
following vesicular fission from the plasma membrane. It was shown that the protein regu‐
lates the actin tail formation [93,94], possibly through binding to cortactin [95-97] or intersec‐
tin, which promotes actin polymerization [98].
Another player in this complex molecular game was recently suggested, following the initial
observation that Cav-1 binds to actin cross-linking proteins, filamin A and B, both in vitro
and in vivo [99]. The main intracellular function of these proteins is to organize the actin cy‐
toskeleton. The Cav-1 filamin A interaction was further confirmed in different cell types
[100,101] and it was implicated in activation of the actin-folding and chaperone protein T-
complex protein-1, [100] and inhibition of calpain-mediated cleavage of filamin A [102].
Caveolae-Dependent Endocytosis in Viral Infection
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Thus, by providing the missing link between Cav-1 and the actin cytoskeleton, filamin is an
important regulator of caveolae-mediated endocytosis and trafficking [103].
It was proposed that following budding, caveolae can fuse with either preformed vesicles,
called “caveosome” at the time of their discovery, or early endosome, the latter process be‐
ing dependent on Rab5 expression [46].
The caveosome was initially described as an immobile structure which did not co-localize
with fluid phase markers or ligands of the clathrin-dependent pathway [104]. Moreover, the
compartment was characterized by neutral pH and was unable to accumulate a lysosomal
dye (lysotracker), reinforcing the notion of an independent organelle, clearly distinct from
other endocytic compartments, which delivers its cargo to other cellular locations, such as
the ER [104,105]. However, in a recent investigation of Cav-1 trafficking using pH-sensitive
fluorophores, the existence of a neutral pH compartment was seriously doubted [106]. Rath‐
er, it was suggested that the caveosomes would correspond to modified late endosomes,
where Cav-1 accumulates when over-expressed, undergoing ubiquitination and being fur‐
ther targeted to degradation [106]. Conversely, under physiological conditions, caveolae
would bud from the plasma membrane transporting their viral cargo to early endosomes
and eventually to the ER, in a microtubule-dependent manner [107], following a series of
maturation events, which will be detailed below.
Clearly, more work is necessary to have the correct picture of the highly atypical caveolar
trafficking, which appears to allow access of its ligands to intracellular destinations that are
not reachable from other endocytic pathways. Despite the remaining uncertainties, the con‐
tinuous development of the field has considerable advanced our knowledge of virus infec‐
tion of host cells using caveolae endocytosis.
The current view of caveolae internalization and trafficking is depicted in Fig. 3.
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Figure 3. Ligand internalization and intracellular trafficking following caveolae-mediated endocytosis
4. Caveolae dependent viral infections
Owing to the vast amount of experimental data characterizing cell infection by the simian
virus 40 (SV40), the pathogen has become the “star” of the caveolae-mediated entry path‐
way, being now extensively used in other studies as a marker of it [104,108]. Other well-
characterized viruses using this entry pathway belong to the polyoma virus family, which
has gained more interest recently, with the increasing number of human viruses identified.
These include the KI polyoma virus, the WU polyoma virus and the Merkel cell polyoma
virus [109-111], the latter being associated with an aggressive form of neuroendocrine skin
cancer, the Merkel cell carcinoma. These are all non enveloped DNA viruses that replicate in
the nucleus.
Caveolae-Dependent Endocytosis in Viral Infection
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Viruses that use the same pathway to initiate a productive infection in target cells are listed
in Table 1. Amongst them, Echovirus 1 (EV1), Human Hepatitis B virus (HBV) [112], Murine
Leukemia Virus (MLV) [113], enteroviruses [114], have been more intensely investigated.
Virus Reference
Simian virus 40
Stang, E., J. Kartenbeck, and R.G. Parton. 1997. Major
histocompatibility complex class I molecules mediate association
of SV40 with caveolae. Mol Biol Cell. 8:47-57.
Pelkmans, L., J. Kartenbeck, and A. Helenius. 2001. Caveolar
endocytosis of simian virus 40 reveals a new two-step vesicular-
transport pathway to the ER. Nat Cell Biol. 3:473-83.
KI polyoma virus
Allander, T., K. Andreasson, S. Gupta, A. Bjerkner, G. Bogdanovic,
M.A. Persson, T. Dalianis, T. Ramqvist, and B. Andersson. 2007.
Identification of a third human polyomavirus. J Virol. 81:4130-6
WU polyoma virus
Gaynor, A.M., M.D. Nissen, D.M. Whiley, I.M. Mackay, S.B. Lambert,
G. Wu, D.C. Brennan, G.A. Storch, T.P. Sloots, and D. Wang. 2007.
Identification of a novel polyomavirus from patients with acute
respiratory tract infections. PLoS Pathog. 3:e64
Merkel cell polyoma
virus
Feng, H., M. Shuda, Y. Chang, and P.S. Moore. 2008. Clonal
integration of a polyomavirus in human Merkel cell carcinoma.
Science. 319:1096-100
Echovirus 1
Marjomaki, V., V. Pietiainen, H. Matilainen, P. Upla, J. Ivaska, L.
Nissinen, H. Reunanen, P. Huttunen, T. Hyypia, and J. Heino. 2002.
Internalization of echovirus 1 in caveolae. J Virol. 76:1856-65.
Stuart, A.D., H.E. Eustace, T.A. McKee, and T.D. Brown. 2002. A
novel cell entry pathway for a DAF-using human enterovirus is
dependent on lipid rafts. J Virol. 76:9307-22
Human Hepatitis B
virus
Macovei, A., C. Radulescu, C. Lazar, S. Petrescu, D. Durantel, R.A.
Dwek, N. Zitzmann, and N.B. Nichita. 2010. Hepatitis B virus
requires intact caveolin-1 function for productive infection in
HepaRG cells. J Virol. 84:243-53.
Murine Leukemia
Virus
Beer, C., D.S. Andersen, A. Rojek, and L. Pedersen. 2005. Caveola-
dependent endocytic entry of amphotropic murine leukemia virus.
J Virol. 79:10776-87
Tiger Frog Virus
Guo, C.J., D. Liu, Y.Y. Wu, X.B. Yang, L.S. Yang, S. Mi, Y.X. Huang,
Y.W. Luo, K.T. Jia, Z.Y. Liu, W.J. Chen, S.P. Weng, X.Q. Yu, and J.G.
He. 2011. Entry of tiger frog virus (an Iridovirus) into HepG2 cells
via a pH-dependent, atypical, caveola-mediated endocytosis
pathway. J Virol. 85:6416-26
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Infectious spleen and
kidney necrosis virus
Guo, C.J., Y.Y. Wu, L.S. Yang, X.B. Yang, J. He, S. Mi, K.T. Jia, S.P.
Weng, X.Q. Yu, and J.G. He. 2011. Infectious spleen and kidney
necrosis virus (a fish iridovirus) enters Mandarin fish fry cells via
caveola-dependent endocytosis. J Virol. 86:2621-31.
Influenza viruses
Nunes-Correia, I., A. Eulalio, S. Nir, and M.C. Pedroso de Lima.
2004. Caveolae as an additional route for influenza virus
endocytosis in MDCK cells. Cell Mol Biol Lett. 9:47-60.
Coronavirus 229E
Nomura, R., A. Kiyota, E. Suzaki, K. Kataoka, Y. Ohe, K. Miyamoto,
T. Senda, and T. Fujimoto. 2004. Human coronavirus 229E binds to
CD13 in rafts and enters the cell through caveolae. J Virol.
78:8701-8
Papillomavirus 31
Bousarghin, L., A. Touze, P.Y. Sizaret, and P. Coursaget. 2003.
Human papillomavirus types 16, 31, and 58 use different
endocytosis pathways to enter cells. J Virol. 77:3846-50
Respiratory syncytial
virus
Brown G, Jeffree CE, McDonald T, Rixon HW, Aitken JD, et al.
Analysis of the interaction between respiratory syncytial virus and
lipid-rafts in Hep2 cells during infection. Virology 2004;327(2)
175-185.
Werling D, Hope JC, Chaplin P, Collins RA, Taylor G, et al.
Involvement of caveolae in the uptake of respiratory syncytial virus
antigen by dendritic cells. J Leukoc Biol 1999;66(1) 50-58.
Newcastle disease
virus
Cantin, C., J. Holguera, L. Ferreira, E. Villar, and I. Munoz-Barroso.
2007. Newcastle disease virus may enter cells by caveolae-
mediated endocytosis. J Gen Virol. 88:559-69
Ebola virus
Empig, C.J., and M.A. Goldsmith. 2002. Association of the caveola
vesicular system with cellular entry by filoviruses. J Virol.
76:5266-70.
BK polyoma virus Eash, S., W. Querbes, and W.J. Atwood. 2004. Infection of verocells by BK virus is dependent on caveolae. J Virol. 78:11583-90.
Marburg virus
Empig, C.J., and M.A. Goldsmith. 2002. Association of the caveola
vesicular system with cellular entry by filoviruses. J Virol.
76:5266-70.
Table 1. Viruses that use caveolae-mediated endocytosis
After binding to the host cell, the virus particles are able to cluster the receptor molecules
such as certain integrins (a2h1 in the case of EV1) [118] or glycosphingolipids (GM1 or GD1a
in the case of SV40 or polyoma viruses), within the lipid rafts [119]. Accumulation of viral
particles in caveolae induces a cascade of tyrosine phosphorylation reactions followed by re‐
arrangements of the cortical actin cytoskeleton, as described above [91].
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Several models addressing virus capturing into the plasma membrane invaginations have
been proposed, the most recent relying on the observation that Cav-1 polymer remains in‐
tact once formed in the Golgi complex, during transport to the plasma membrane. Accord‐
ing to this model, caveolae result from the fusion of a pre-existing caveolar vesicle with the
plasma membrane [46]. As a consequence of virus binding to an increasing number of
sphingolipids and/or integrins, the affinity of the pathogen for caveolar domains increases,
facilitating entrapment in these areas. Another possibility is that virus particles bind and re‐
lease the plasma membrane gangliosides in a transient manner, thus screening the whole
cell surface. When reaching a caveolar region where multiple gangliosides interactions can
occur simultaneously, binding becomes permanent and the virus particles are sequestered
[104].
The intracellular trafficking of caveolae cargos has been recently re-evaluated using SV40 as
a model and a series of complementary, state-of-the art techniques, including live-cells and
electron microscopy, video recordings, pharmacological inhibitors and inhibition of expres‐
sion of trafficking regulators [120]. It was shown that productive SV40 infection depends on
the virus transport through a series of classical endocytic vesicles. Initially, the virus is
found in Rab5-, EEA1-positive early endosomes and subsequently becomes associated with
Rab7-positive domains, during endosome maturation. As this process proceeds, SV40 co-lo‐
calizes with LAMP1-, Rab9-, and Rab7-positive late endosomes resembling multivesicular
bodies and possibly endolysosomes. Endosome maturation also involves acidification of the
compartments, as a consequence of vacuolar ATPase (v-ATPase) recruitment and activity.
At this stage, acidification is required for SV40 subsequent transport steps and the initiation
of productive infection. Interestingly, BK and JC viruses were also shown to enter the endo‐
somes and depend on acidification for infection [121-123]. In the case of the mouse polyoma
virus, the recycling, as well as late endosomes have been involved in infection [124,125].
From the late compartments of the endocytic pathway, SV40 appears to be directly trans‐
ported to the ER, although an indirect ER targeting, via the Golgi complex, has not been
completely excluded. Similarly, other polyoma viruses are transported to the ER lumen, be‐
fore reaching the nucleus [121,125].
However, there are some notable exceptions of virus trafficking diverting from this path‐
way, despite being internalized through caveolae. Thus, cellular penetration of the EV1, a
positive-stranded RNA human pathogen, depends on caveolins, dynamin II, and signaling
events but does not require actin filaments or microtubules. The virus uptake was much
faster than that of SV40 and was followed by rapid co-localization with Cav-1. Beyond this
step, the virus failed to enter the Golgi complex, the ER, or the lysosomes, as none of the
markers used to label these organelles co-localized with viral proteins. This observation
raised the hypothesis that the virus particles remain sequestered in the Cav-1 positive endo‐
cytic vesicles until replication is initiated, further using them for cytoplasmic penetration
and uncoating.
The lack of transport to the ER or Golgi was also confirmed by the absence of any inhibition
of infection in the presence of nocodazole. Although more experimental data is needed to
substantiate it, it is tempting to speculate that the different sorting pathway of the two virus‐
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es is related to their replication mechanism; thus, a DNA virus such as SV40 needs the nu‐
cleus for replication, which might be more accessible through the ER, whereas for a positive-
stranded RNA virus the release of the genome into the cytoplasm is sufficient to initiate
replication.
Either way, the precise molecular details characterizing this segment of the trafficking path‐
way are still to be defined, but understanding the factors involved in these unusual traffick‐
ing pathways is crucially important as other, yet uninvestigated viruses, may well use them
when accessing the host cell via caveolae.
Importantly, there is accumulating evidence suggesting that several viruses take advantage
of cross talk between endocytosis routes. For instance, JCV, bovine papillomavirus type 1
and human papillomavirus type 16 have been shown to access cells using the clathrin-de‐
pendent endocytosis, but intriguingly, they require Cav-1-mediated trafficking to initiate
productive infection [123,126,127]. The internalized virions were trafficked to early endo‐
somes before being transported to the caveolar pathway. From the Cav-1-positive vesicles,
the viral cargo is further moved to the ER in a COPI-mediated, BFA-sensitive manner [127].
The newly described trafficking routes taken by these viruses may have an explanation in
their absolute requirement to reach the ER compartment, a target that is not on the clathrin-
mediated route.
The intriguing question as to why these viruses travel to the lumen of the ER, instead of us‐
ing the endosomes for genome release, have received several interesting answers lately. One
possibility is that the pathogens take advantage of the ER machinery of folding enzymes
and chaperones, for uncoating and membrane penetration, being activated by lumenal thiol
oxidoreductases before release into the cytosol/nucleoplasm [128].
Very recently, BiP and the ER-membrane protein BAP31 (both involved in ERAD) were
shown to be essential factors for SV40 infection; thus incoming SV40 particles are structural‐
ly remodeled leading to exposure of the amino-terminal sequence of the minor viral protein
VP2. These hydrophobic sequences anchor the virus to the ER membranes helping the parti‐
cles release into the cytosol [129].
5. Investigation of the caveolae entry pathway
The molecular details of virus entry have been investigated through a variety of techniques,
by perturbing endocytotic internalization with various inhibitors or interfering with the ex‐
pression or function of key regulator proteins, using siRNA or dominant-negative mutants
of the proteins, or by using transgenic animals. Because no single method to assess caveolae
is perfect, the use of complementary techniques is crucial for such a task. These can employ
cell fractionation, immunoprecipitation, protein and organelle labeling, immunofluores‐
cence microscopy. Since caveolae are best characterized by their microscopic appearance,
studies employing alteration of the intracellular level of caveolins, cholesterol, or different
molecules enriched, but not exclusively present in caveolae, should ideally follow the im‐
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pact of such changes to other internalization and trafficking pathways, by electron microsco‐
py
5.1. Pharmacological approaches
A pharmacologic approach involves the treatment of cells with agents that deplete mem‐
branes of cholesterol, or inhibit various structural or signaling molecules involved in con‐
trolling the pathway. Having the advantage of being readily available and convenient to
use, chemical inhibitors have been extensively employed to characterize different endocytic
pathway; however, stringent controls must be included and results should be interpreted
with care, because of the pleiotropic effects these drugs may have within the treated cell.
The usefulness as well as the pitfalls associated with the use of these agents will be detailed
below.
Methyl-β-cyclodextrin (MβCD) – Cyclodextrins are cyclic oligomers of glucose that have the
property to bind and extract lipophiles, including cholesterol, from their hydrophobic core
[130]. Based on the tight dependency of caveolae stability and function on the amount of
cholesterol present in the lipid rafts, the compound has been widely used to define the cav‐
eolar-mediated entry of many pathogens [6,117,131-135].
A major issue of MβCD treatment is its cellular toxicity, which was initially associated with
longer incubation times (for example, the cell viability decreases form 90% during a 30 mi‐
nutes incubation, to as low as 64%, if the drug is used for 12 h) [117]. A thorough study per‐
formed on multiple cell lines showed, however, that MβCD significantly decreased cellular
viability, even after short treatment and at concentrations routinely used to inhibit endocy‐
tosis, a phenomenon which was cell line dependent [136]. Moreover, a low level of plasma
membrane cholesterol was shown to interfere with other endocytic pathways, such as the
clathrin-mediated endocytosis [137,138], or even with cholesterol independent endocytosis
[139], demonstrating a rather poor specificity of the drug in inhibiting a distinct pathway.
Statins – are a group of drugs that lower the intracellular cholesterol level by competitively
inhibiting the 3 hydroxy 3 methylglutaryl coenzyme A reductase involved in its biosynthe‐
sis. As a consequence, efficient depletion of membrane cholesterol and decreased formation
of caveolae are observed [140]. Despite showing good toxicity profiles, statins also exert plei‐
otropic effects through a variety of mechanisms, which appear to be unrelated to their cho‐
lesterol-lowering activity. Thus, several immunosuppressive effects have been involved;
amongst them well-documented are the prevention of activation of the transcription factor
NF-kappaB or up-regulation of the pro-inflammatory cytokine production [141,142].
Filipin - is a macrolide pentene polyene with antibiotic properties relying on sterol binding
with high affinity [143]. Filipin III has been employed to block caveolae entry since it com‐
plexes with membrane cholesterol, thus interfering with cholesterol-sensitive processes
[144]. Treatment with filipin dispersed the receptors found in caveolae and promoted disas‐
sembly of these structures [145]. Similar to MβCD, filipin treatment is toxic and at least for
certain cell lines, its inhibitory effect on endocytosis was exclusively due to cytotoxicity
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[146]. However, a narrow window of specific inhibitory function can be identified in most
cell lines.
Genistein – inhibits several tyrosine kinases in mammalian cells and thus, caveolae internali‐
zation [86,147]. Genistein has been however shown to suppress the entry of several types of
viruses that use different endocytic ways to gain access to the replication sites: SV40 [91],
adenoviruses [148], human herpesvirus 8 (HHV-8) [149], HBV [112]. However, the general
need of tyrosine kinases-mediated signaling of diverse families of viruses, both at early en‐
try steps, or later in infection, makes it difficult to clearly ascertain the endocytic route used,
only by using genistein.
U18666A - is an amphiphilic amine that arrests cholesterol transport and suppresses sterol
biosynthesis. Treatment of cells with this inhibitor was shown to induce cholesterol accumu‐
lation in late endosomes/lysosomes and deplete cholesterol from the Golgi complex [150].
Interestingly, the mobility of Cav-1 significantly increased in the Golgi complex of U18666A-
treated cells.
Phorbol 12-myristate 13-acetate (PMA) – is an activator of classical 2,3-diacylglycerol (DAG)-
dependent protein kinase isoforms, owing this property to their high affinity for the DAG
binding site. Interestingly, PMA treatment results in constitutive phosphorylation of caveo‐
lin [151] with significant inhibitory effects on caveola invagination from the intracellular
face of the plasma membrane [86,152,153].
PMA has been shown to specifically inhibit the caveolae-mediated entry of Ebola and Mar‐
burg viruses, two negative-stranded RNA pathogens, members of the Filoviridae family
[154]. PMA has a low citotoxicity even when used for longer incubation times (82% of the
cell are still viable following incubation for 24 h, at concentrations required to inhibit caveo‐
lae endocytosis [117].
It is important to note that PMA can stimulate endocytosis of other ligands and interferes
with the endocytic trafficking by stimulating a factor required for endosome fusion after
Rab5 activation [155]. PMA treatment may have opposite effects on internalization of certain
ligands (such as FITC-dextran) in polarized cells, increasing for instance, its basolateral, but
not apical uptake.
Okadaic acid – is an inhibitor of phosphatases 1 and 2A, which are important in caveolae
function [156]. Treatment with okadaic acid has been shown to promote removal of caveolar
structures from the cell surface and stimulate endocytosis via these structures [6,86]. Impor‐
tantly, the drug also inhibits the clathrin-mediated endocytosis [86] making the time of addi‐
tion to the cells an important experimental factor in drawing the right conclusions on viral
entry. Thus, pretreatment of cells with okadaic acid interferes with both, caveolae and cla‐
thrin pathways, while addition after virus binding to the target cells enhances infection, as it
was shown for MLV [113].
Cytoskeleton inhibitors - the actin cytoskeleton localized near the plasma membrane appear to
be a critical regulator of caveolae endocytosis [157].
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Depolymerization of microtubules with colchicine or disruption of actin microfilaments
with cytochalasin D resulted in a significant reduction of the amount of Cav-3 in plasma
membrane fractions isolated from cardiac myocytes. Treatment with either drug also led to
the exclusion of Cav-1 and -2 from similar fractions and the decrease of tyrosine-phosphory‐
lated Cav-1 [101].
Other drugs interfering with actin polymerization are latrunculin A (actin monomer-seques‐
tering drug) and jasplakinolide (an actin polymer-stabilizing compound), both were shown
to reduced SV40 internalization by more than 60% [91]. Since function of many cellular proc‐
esses such as trafficking and organelle movement are regulated by microtubules and the ac‐
tin cytoskeleton, the biochemical assays should be combined with microscopy analysis to
clearly define the role of the cytoskeleton in viral infection mediated by caveolae. Also, it is
important to keep in mind that viruses induce cytoskeletal reorganization and reconfigura‐
tion to initiate, maintain and spread the infection. Therefore, the impact of the cytoskeleton
perturbation on the outcome of infection highly depends on the stage of the viral life cycle
the drug is acting upon [158].
5.2. Interference with expression and function of caveolae regulating proteins
As threshold levels of Cav-1 regulate caveolae formation [155,159,160], modulating the ex‐
pression and/or function of this protein is one the most reliable approach to investigate cav‐
eolae entry. Cav-1 down-regulation using anti-sense, small interfering (si) or short hairpin
(sh) RNA results in a significant decrease in the number of caveolae. For instance, the siR‐
NA-mediated knockdown of Cav-1 expression was sufficient to inhibit albumin uptake in
endothelial cells; however, intriguingly enough, the caveolae localization of signaling pro‐
teins, including eNOS, Rac, tyrosine kinase Src and insulin receptor was not altered. Using
this technique, several viruses were shown to depend on caveolae for productive infection
such as the Avian Reovirus [161], BK polyomavirus [133].
Cavin proteins are also important targets to study caveolae-mediated entry, since absence of
cavin-1 results in lower expression level of caveolins and eventually, the loss of caveole.
Down-regulation of cavin-1, using specific shRNA, increases mobility of caveolin-1, which is
released from the cell surface and rapidly internalized and degraded [39]. Interfering with
cavin-2 expression is also a valuable tool when assessing the role of caveolae in viral infec‐
tion, since its down-regulation induces loss of cavin-1 and caveolin expression and there‐
fore, it limits caveolae formation [43]. Similarly, suppression of cavin-3 biosynthesis
uncouples caveolae from the intracellular transport machinery [44].
Caveolae budding from the plasma membrane and subsequent internalization strictly de‐
pends on dynamin II [89], thus silencing its expression is also often used in combination
with caveolin inhibition.
An elegant alternative to silencing the expression of the proteins involved in caveolae archi‐
tecture and function is over-expression of their mutant counterparts, which compete with
the wild-type proteins for the same function. An important advantage of this technique is
that, at any time during the experiment, the wild-type protein is still expressed ensuring the
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functioning of the pathway at a basal level and reducing toxicity. This approach was used to
show the dependence of HBV internalization on functional Cav-1 and dynamin II (Fig. 4)
[112].
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Figure 4. Hepatitis B Virus (HBV) infection of permissive HepaRG cells stably expressing dynamin II (A and B) and cav‐
eolin-1 (C and D) proteins with either wild-type (A and C) or dominant-negative (B and D) functions. HBV infection is
evidenced by immunofluorescence microscopy using antibodies against the envelope proteins (in red). The dominant-
negative dynamin II contains the K44A mutation which abolishes the GTP-ase activity (B). The dominant negative cav‐
eolin-1 contains a deletion of the 1-81 amino acid domain, at the N-terminal end (D). Expression of the wild-type and
dominant-negative variants is evidenced through the Green Fluorescent Protein (GFP), which is either co-expressed
from bicistronic GFP-caveolin DNA constructs (C and D) or expressed in fusion with dynamin II (A and B).
Cav -1 dominant negative proteins – disturb the formation of Cav-1-positive lipid rafts and
cause the redistribution of endogenous caveolin to detergent soluble membrane fractions
[162]. These are N-terminally truncated or N-terminally GFP-tagged caveolin constructs,
which strongly inhibit SV40 entry [104,163] and were used to characterize the internalization
pathway of many other viruses [134,164,165].
Other caveolin constructs containing the point mutations, Y14F and P132L were recently
demonstrated to have dominant-negative activity [166]. Expression of the Cav-1 variant con‐
taining the P110A mutation was shown to determine a profound inhibition of caveolae en‐
docytosis, cellular lipid accumulation and lipid droplet biogenesis. Moreover, this is a
potent mutant to take into account when investigating the caveolae pathway, as it signifi‐
cantly reduces the Cav-1 localization into detergent-resistant domains of the plasma mem‐
brane and caveolae formation [22].
An interesting caveolin mutant is cavDGV, a deleted Cav-3 form, which lacks the first 53 resi‐
dues of the protein, but contains an intact scaffolding domain. The truncated protein acts as
a dominant negative inhibitory mutant, causing the intracellular accumulation of free cho‐
lesterol in late endosomes, a reduction of surface cholesterol, efflux and synthesis [30].
Dynamin -II dominant negative proteins - as important regulators of clathrin, caveolae and
other endocytic pathaways [88,167], dynamin II inhibition is often used in combination with
modulation of other, more specific proteins involved in caveolae function (listed above). By
far, the most used mutant dynamin is the K44A variant, defective in GTP hydrolysis, which
was clearly shown to inhibit release of caveolae from plasma membranes in an in vitro assay
[89].
A long term expression of a dominant negative protein may be toxic for the cells, determin‐
ing changes of morphology. Also it is important to keep in mind that down-regulation of a
certain pathway may promote up-regulation of other, compensatory entry mechanisms, if
cells express dominant negative proteins for a long time. A solution to overcome these po‐
tential problems is the use controlled/inducible expression systems (such as the TetOn/Tet
Off switch).
Generation of knockout (KO) mice – is a powerful approach for the study of caveolae in
vivo. Caveolin-KO mice (Cav-1, -2, -3 and Cav-1/-3 double KO mice have already been gen‐
erated and characterized. They displayed different phenotypes, but interestingly, were via‐
ble and fertile [168]. While Cav-2 KO mice retain normal expression of caveolae, Cav-1 KO
mice are devoid of Cav-2 expression and caveolae in certain cell lines, and develop many
cardiac and pulmonary diseases. More work is needed to understand whether or not these
pathologies are directly correlated with the loss of expression of caveolins and caveolae and
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a good approach toward this aim would be to investigate each individual caveolins and the
development of the corresponding phenotypes over a longer period of time.
6. Concluding remarks
The new experimental evidence emerged with the advance of the techniques used to investi‐
gate ligand internalization and intracellular trafficking, have consolidated the notion that
endocytosis through caveolae is a true alternative to the clathrin-mediated pathway. By em‐
ploying this route for entry into the target cell, viruses could benefit from the enormous ad‐
vantage of being targeted directly to specific organelles that are essential for their
replication; moreover, degradative compartments can be bypassed, which could enhance
the efficiency of productive infection. Nevertheless, despite the tremendous development of
the field in the last decade, many conceptual and mechanistic aspects are still to be clarified
or reevaluated. Certainly, important issues regarding: a) the regulation of the crosstalk be‐
tween different internalization pathways; b) the similarities between caveolae and other cla‐
thrin-independent entry routes; c) the exact mechanism of ligand sorting; d) the properties
of the compartment(s) where it occurs; d) the preferential targeting of caveolae ligands to
other intracellular compartments than the ER; are already under the scrutiny of many cell
biologists and will find an answer in the near future.
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